Gold and Silver Decline as Precious Metals Retreat from Recent Highs Adani Group Companies Rally Recoup Nearly 150 Billion in Market Value Lost After Hindenburg Report AI Hallucinations Are Infiltrating Expert Work Raising Concerns for Knowledge Integrity and Professional Liability USIran Tensions Snowflake Surge Robinhood AI Morning Market Highlights OpenAIs IPO Plans A Potential RecordBreaking Market Debut Amid Competition with SpaceX Singapores Young Professionals Earn High Incomes but Struggle with Financial Insecurity Amid Rising Living Standards Exicure XCUR Q2 2022 Earnings WiderThanExpected Loss Fails to Deter Investors DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress ADAM Q1 2026 Earnings Strong Earnings Beat Drives Stock Up 247 Youdao Inc Q1 2026 Earnings EPS Misses Estimates but Stock Surges on Broader Sentiment ANI Pharmaceuticals Q1 2026 Earnings Major EPS Beat Belies Subdued Market Response SOTK Q1 2026 Earnings EPS Misses Estimates by 216 Stock Rises 39 Old Republic International ORI Edges Lower Remains Within Established Range PAVmed Inc PAVM Gains 244 as Stock Tests Key Resistance Near 662 Meta Platforms META Holds Steady Near 610 as Bulls Eye Resistance Levels Hawaiian Electric HE Gains Modestly as Support Holds Above 13 AZZ Inc AZZ Consolidates Near Resistance After Slight Decline Intuit Earnings Results Challenge Morgan Stanleys Stock Outlook SHW Q1 2026 Earnings EPS Beats Estimates with 306 Surprise Revenue Details Not Provided VSE Corporation VSEC Shows Strength Stock Advances 21 Amid Positive Momentum Ferrari Shares Slip After Unveiling First Fully Electric Model the Luce Texas Files Lawsuit Against Meta and WhatsApp Over Encryption Privacy Claims Gold Under Pressure Bearish Momentum Builds as Potential Test of 4444 Comes into Focus Broadcom Meta and Tech Giants Commit 125 Million to Semiconductor Research Hub at UCLA Historic Fed Overlap Powell and Warsh to Coexist at June FOMC Meeting Soybean Futures Edge Lower Amid Growing Supply Concerns BioMarins BMN 401 Phase 3 Trial Shows Mixed Results in ENPP1 Deficiency